Introduction
More than 5500 individuals become living kidney donors (LKDs) each year in the United States (1) . The Organ Procurement and Transplantation Network (OPTN) maintains a national registry of LKDs. Much of our current knowledge of postdonation outcomes for LKDs comes from studies that have linked this registry to external data sources, including other registries and administrative claims (2) (3) (4) (5) (6) (7) . Due to incomplete follow-up in the registry, most granular inferences about postdonation and longterm health outcomes have been limited to single-center or small multicenter studies . A survey published in 2013 reported that approximately 40% of transplant centers lost contact with >75% of LKDs within 2 years postdonation (33) . Barriers to living donor follow-up (LDF) frequently reported by transplant centers include donor inconvenience for medical tests, out-of-date contact information, lack of reimbursement for follow-up services, and direct and indirect costs to donors (33) .
In 2013, the OPTN/United Network for Organ Sharing (UNOS) responded to a Health Resources and Services Administration (HRSA) directive to develop policies regarding living donor care (informed consent, evaluation, and follow-up) in accordance with other OPTN policies (34) . This 2013 OPTN/UNOS policy requires transplant centers to achieve specific thresholds for collecting and reporting clinical and laboratory data for LKDs at 6 months, 1 year, and 2 years postdonation, respectively (35) . For LKDs donating after December 31, 2014, transplant centers are required to report clinical data for 80% and laboratory data for 70% of donors (35) . across centers. To understand the impact of this policy change, we explored the national landscape of LDF and identified donor-and center-level characteristics associated with complete and timely LDF by using multilevel logistic regression.
Methods

Data source
This study used data from the Scientific Registry of Transplant Recipients (SRTR) external release made available in June 2016. The SRTR data system includes data on all donors, waitlisted candidates, and transplant recipients in the United States, submitted by members of the OPTN, and has been described elsewhere (2) . The HRSA, US Department of Health and Human Services, provides oversight to the activities of the OPTN and SRTR contractors.
Study population
We studied 31 615 LKDs who donated between January 1, 2010, and June 30, 2015, of whom 13 496 (42.7%) donated after the implementation of the OPTN/UNOS LDF policy on February 1, 2013 . Follow-up data through February 29, 2016 , were included.
Policy definitions
Transplant centers were encouraged to submit LDF forms before 2013, and required to do so after the policy change. Under the 2013 OPTN/UNOS policy, LDF forms collect data on nine clinical and two laboratory components (35) . The clinical components are: vital status, income, loss of medical insurance, recent hospitalizations, kidneyrelated complications, dialysis, hypertension, diabetes, and cause of death (if applicable). The laboratory components are serum creatinine and urine protein levels. According to the OPTN/UNOS policy definitions, complete LDF forms must contain responses to all clinical and laboratory components and timely LDF forms must be submitted within a 60-day window before or after the 6-month, 1-year, or 2-year donation anniversary. According to the policy guidelines, centers were considered noncompliant if they missed any reporting threshold at any time point.
Policy reporting thresholds
Under the 2013 OPTN/UNOS policy, the minimum reporting thresholds for clinical and laboratory data increased over time. Centers were required to submit clinical data for at least 60% of LKDs and laboratory data for at least 50% of LKDs who donated between February 1, 2013, and December 31, 2013. For donations occurring between January 1, 2014, and December 31, 2014, clinical and laboratory data were required to be reported for 70% and 60% of LKDs, respectively. For donations after January 1, 2015, submissions of clinical data and laboratory data were required for 80% and 70% of LKDs, respectively.
Inclusion and exclusion criteria
Using the policy submission guidelines, we studied 6-month, 1-year, and 2-year postdonation LDF. We excluded donors with insufficient postdonation follow-up time, restricting analyses of 2-year LDF to 2013 LKDs and 1-year LDF to 2013 and 2014 LKDs. For complete reporting, centers were required to capture only vital status for donors who died. Donors who died before the end of a given follow-up window (60 days after their expected visit date) were considered eligible for LDF at that time point and ineligible for future time points. Donors who were marked lost to follow-up for any time period were considered eligible for future follow-up time points.
Statistical analysis
We used multilevel logistic regression to measure (1) the association between the 2013 OPTN/UNOS LDF policy implementation and complete and timely LDF form submission and (2) the association of donor-and center-level characteristics with incomplete or nontimely LDF.
We modeled change in LDF in two ways, allowing for different assumptions about the underlying temporal trends. The first set of models used a policy period indicator to estimate the effect of the policy period (pre vs. post). These models calculated the adjusted odds ratio (aOR) of complete and timely LDF, after adjusting for calendar time and donor-and center-level characteristics (described next). An aOR >1 indicated that there was a higher chance of complete and timely LDF in the postimplementation period, after adjusting for relevant covariates. The second set of models used a difference-in-differences (DID) framework to estimate the marginal change in the rate of LDF by policy period and allowing the LDF rate to differ by policy period (pre vs. post). This DID model captured not only direct policy-related changes in LDF measured postimplementation but also potential policy-related changes that occurred before actual implementation while the policy was being discussed and considered. A ratio of marginal change >1 indicated that the LDF rate grew faster after the policy was implemented.
Functional forms of categorical variables were chosen by using commonly published standards or residual plot analyses. The specifications of the random-effects models were assessed by using likelihood-ratio tests. Confidence intervals (CIs) were reported according to the method of Louis and Zeger (37) . All analyses were performed by using Stata 14.2/ MP for Linux (College Station, TX).
Model specification
We adjusted for donor characteristics, including age, sex, race (African American vs. non-African American), ethnicity (Hispanic vs non-Hispanic), geographic location relative to the transplant center (in-state, out-of-state, or international), educational attainment (high school or lower, attended college, college degree, or postgraduate degree), marital status (single, married, divorced/separated, or widowed), relationship to the kidney recipient (spouse, nonspousal family member, kidney exchange participant, or other), employment status, insurance status, history of hypertension, history of smoking, body mass index (BMI), and estimated glomerular filtration rate (eGFR) immediately before donation. We also adjusted for center characteristics, including LKD program size (defined as the median number of LKDs per year during the study period). Recipient characteristics (age, sex, race, and insurance status) were examined during exploratory data analyses and excluded from our final models as they did not appear to confound the associations of interest. All statistical models contained random intercepts to account for center-based clustering. The addition of a third level to account for region-based clustering was explored but was excluded from the final models as there was no observed variance across regions. After exploring levels and patterns of missingness in both the general study population and the postpolicy subgroup, we assumed that these covariates were missing-at-random. We imputed missing covariate values using multiple imputation by chained equations incorporating fully conditional specification of prediction equations (38) . For sensitivity analyses, we restricted to complete cases (LKDs with no missing baseline covariates).
Results
Study population
Compared with the prepolicy period (January 2010 through January 2013), LKDs in the postpolicy period (February 2013 through June 2015) were less likely to be biological relatives of the recipient and were more likely to be older (≥65 years), insured, employed, college educated, to have a history of smoking and of hypertension, to have a lower predonation eGFR, and to live outside the United States (Table 1) . Of 31 615 LKDs in our study population, 26 301 (83%) had no missing baseline covariates. The characteristics with the highest levels of missing data were insurance status (9%) and education (6%). Of the 13 496 LKDs who donated postpolicy, 12 227 (91%) had no missing baseline covariates. In this group, the characteristics with the highest levels of missing data were also insurance status (4%) and education (4%).
Proportions of 2-year LDF by policy period
The proportion of complete and timely LDF form submissions increased each year between 2010 and 2015 for clinical and laboratory data for 6-month, 1-year, and 2-year LDF (Figure 1 ). Postpolicy, complete and timely 2-year LDF increased independently for clinical data (49% to 65% of LKDs, p < 0.001) and for laboratory data (37% to 56% of LKDs, p < 0.001) ( Table 2) . For clinical data, the level of 2-year LDF reporting in the postpolicy period varied by component from vital status (73%), readmission since last visit (68%), kidney complications (68%), maintenance dialysis (68%), diabetes (68%), working for income (67%), and hypertension (66%), to cause of death (when applicable) (50%). For laboratory data, reporting was higher for serum creatinine (60%) than for urine protein (56%) for 2-year LDF postpolicy. Complete and timely submission of both clinical and laboratory data together, the primary outcome, increased from 33% to 54% postpolicy for 2-year LDF (p < 0.001) (Figure 2 ). Urine protein or protein:creatinine ratio. 4 Excludes donors in 2015. 4, respectively) . The donor characteristics associated with increased odds of 2-year LDF were consistent across both the indicator and marginal change models and include female sex, younger age, college-level education or higher, and residence in the same state as the transplant center. There were no differences in inferences between the primary results using multiple imputation and the complete-case sensitivity analyses (data not shown).
Center LDF submission by policy-defined thresholds Only 43% (87/202) of centers submitted complete and timely 6-month, 1-year, and 2-year LDF forms that met the policy-defined thresholds for 2013 LKDs (Table 5 ). An additional 23% of centers (46/202) submitted complete LDF forms for 2013 LKDs at the policy-defined threshold level outside the required reporting time window. Among centers not meeting policy-defined thresholds for 2013 LKDs, the median proportion of complete and timely 2-year LDF was 59% (IQR 41-79%) for clinical data and 50% (IQR 33-67%) for laboratory data ( Figure 3 ). Fifty-five percent (113/204) of centers submitted complete and timely 6-month and 1-year LDF forms at the level required by the policy for LKDs in 2014, and 57% (108/190) met required thresholds for 2015 LKDs. Among centers not meeting policy requirements for LDF, the proportion of complete and timely LDF ranged from 0% to the threshold of compliance. Of these centers, 65% fell below the minimum thresholds due to incomplete forms. These difference-in-differences models assess separate associations with calendar time before and after the implementation of the OPTN/UNOS LDF policy on February 1, 2013, by using linear splines. For example, from the unadjusted model, 2-year LDF increased by 22% each year before implementation of the policy and 37% each year after implementation of the policy, but this marginal change was not statistically different (p = 0.5). In both the unadjusted and adjusted models, there was a statistically significant increase in the rate of timely and complete 6-month LDF following the implementation of the 2013 LDF policy but no evidence of a difference in LDF at 1 and 2 years. LDF, living donor follow-up; OPTN, Organ Procurement and Transplantation Network; UNOS, United Network for Organ Sharing. Unadjusted for donor-level characteristics. 2 Models adjusted for donor demographics (body mass index, history of hypertension, history of smoking, eGFR, education status, marital status, relationship to recipient, employment status, income status, geographic location) and median LKD program size. 3 The annualized change was calculated by dividing the estimated rate of LDF from the difference-in-differences models by the number of years in that time period (i.e. 3.08 years prepolicy and 2.42 years postpolicy). Table 6 ). There were no differences in inferences drawn between the primary results and the complete-case sensitivity analyses (data not shown).
Center-level variation in LDF form submission
The odds of nontimely or incomplete LDF form submission varied significantly by center (p < 0.001) (Figure 4 ). For 6-month LDF, center-level variation accounted for 19% and 20% (interclass correlation: 0.19, 95%CI: 
Discussion
In this study of national registry data, we found that the proportion of complete and timely LDF form submission increased each year between 2010 and 2015. The proportion of LKDs with complete and timely 2-year LDF increased from 33% to 54% after the implementation of the 2013 OPTN/UNOS LDF policy. Our DID model showed a prepolicy increase in LDF of 20% per year for 6-month and 1-year LDF and 22% per year for 2-year LDF. These prepolicy increases in LDF may be attributable to the public comment process and consensus conferences (39) . Despite increases in LDF, only 43% of centers met all the policy requirements for 2013 LKDs.
Studies have shown that postdonation follow-up presents logistical and financial challenges for both donors and centers (33, 40) . Despite the 2013 policy change, these barriers remain because there is no formal mechanism to reimburse donors or centers for the costs of complying with this LDF mandate. Centers for Medicare and Medicaid Services provider manual revisions clarified that the 6-month, 1-year, and 2-year follow-up required by the OPTN/UNOS are not allowable as organ acquisition costs on the Medicare Cost Report and cannot be billed to the recipient's Medicare as routine or complicationrelated care (36) . Thus, options for covering the costs of follow-up for donors to Medicare beneficiaries include requiring donors to use their own insurance or establishing separate charitable funds for centers attempting to legally cover follow-up costs for their donors.
Center-based initiatives to provide long-term donor follow-up and support through integrated laboratory and clinical monitoring, expansion of preventive health strategies, and social networks between past, current, and future donors are being pilot tested (41) . A recent singlecenter study suggests that initiatives with dedicated program resources can result in more accurate and complete follow-up (42) . In addition, the SRTR has recently enrolled several transplant centers in an HRSA-sponsored pilot "Living Donor Collective" to test the feasibility of LDF through the SRTR. Finally, efforts could be made to clarify that the National Organ Transplant Act prohibition on "valuable consideration" for an organ does not include the provision of routine, mandated follow-up care.
In conclusion, 57% of transplant centers did not meet national reporting thresholds under the 2013 OPTN/ UNOS mandate despite yearly increases in LDF since 2010. This study was not able to determine additional barriers to LDF submission; however, the identification of donor-and center-level characteristics associated with nontimely or incomplete might inform future studies. Another limitation of this study was the availability of follow-up data since the implementation of the 2013 OPTN/ UNOS policy. Center-level compliance with the policy could be assessed only for 2013 LKDs. However, because the OPTN/UNOS policy requires all thresholds to be met, we show that only 55% of centers have the potential to meet the policy-defined thresholds for 2014 LKDs (Table 5 ). Future research is needed to define the optimal time points, data elements, form of data capture, and most effective implementation strategies to systematically capture and study outcomes after living kidney donation. 
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